RHUMBLINE ADVISERS - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 48 filers reported holding OVID THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$317,909
+23.0%
82,791
+5.1%
0.00%
Q2 2023$258,359
+31.1%
78,768
+60.8%
0.00%
Q1 2021$197,000
+71.3%
48,990
-1.4%
0.00%
Q4 2020$115,000
-56.8%
49,670
+7.3%
0.00%
Q3 2020$266,000
-25.1%
46,280
-4.0%
0.00%
-100.0%
Q2 2020$355,000
+1083.3%
48,225
+183.5%
0.00%
Q1 2019$30,000
-25.0%
17,010
+2.8%
0.00%
Q4 2018$40,000
-37.5%
16,551
+47.2%
0.00%
Q3 2018$64,000
-30.4%
11,241
-4.9%
0.00%
Q2 2018$92,00011,8160.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,000,000$7,820,0004.09%
BVF INC/IL 6,631,051$25,927,0000.97%
EcoR1 Capital, LLC 6,082,200$23,781,0000.89%
GLOBEFLEX CAPITAL L P 1,009,125$3,946,0000.71%
Ikarian Capital, LLC 1,124,872$4,398,0000.36%
CHI Advisors LLC 218,510$854,0000.20%
Artal Group S.A. 2,500,000$9,775,0000.20%
DCF Advisers, LLC 139,701$546,0000.19%
Tibra Equities Europe Ltd 78,700$308,0000.10%
XTX Topco Ltd 50,569$198,0000.07%
View complete list of OVID THERAPEUTICS INC shareholders